Cleared Traditional

K150155 - NOVA Lite DAPI ANA Kit (FDA 510(k) Clearance)

Apr 2015
Decision
75d
Days
Class 2
Risk

K150155 is an FDA 510(k) clearance for the NOVA Lite DAPI ANA Kit. This device is classified as a Antinuclear Antibody, Indirect Immunofluorescent, Antigen, Control (Class II - Special Controls, product code DHN).

Submitted by Inova Diagnostics, Inc. (San Diego, US). The FDA issued a Cleared decision on April 8, 2015, 75 days after receiving the submission on January 23, 2015.

This device falls under the Immunology FDA review panel. Regulated under 21 CFR 866.5100.

Submission Details

510(k) Number K150155 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 23, 2015
Decision Date April 08, 2015
Days to Decision 75 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Summary PDF

Device Classification

Product Code DHN — Antinuclear Antibody, Indirect Immunofluorescent, Antigen, Control
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.5100